Abstract
-
Purpose
- To compare perioperative and oncologic outcomes between robotic and laparoscopic colectomy for colon cancer, with a focus on peritoneal recurrence, using a propensity score–matched analysis.
-
Methods
- We retrospectively reviewed 591 patients who underwent minimally invasive colectomy for colon cancer between 2016 and 2024. After 1:1 propensity score matching based on age, sex, body mass index, American Society of Anesthesiologists physical status, clinical stage, and procedure, 90 patients in each group were analyzed. Survival outcomes were assessed using Kaplan-Meier methods and competing risk analysis with the Fine-Gray model.
-
Results
- Robotic colectomy showed lower blood loss (median, 10 mL vs. 20 mL; P<0.001), shorter postoperative hospital stay (median, 9 days vs. 11.5 days, P<0.001), and a higher rate of intracorporeal anastomosis (92.2% vs. 24.4%, P<0.001), without prolonging operative time. Disease-free survival was comparable (P=0.519). Locoregional/peritoneal recurrence-free survival was higher in the robotic group (P=0.037); however, competing risk analysis using the Fine-Gray model showed no significant difference in the cumulative incidence of locoregional/peritoneal recurrence between groups. Multivariable analysis identified high-grade histology as an independent predictor of peritoneal recurrence, whereas surgical approach was not.
-
Conclusion
- Robotic colectomy provides favorable perioperative outcomes while maintaining oncologic safety comparable to laparoscopic colectomy. Peritoneal recurrence appears to be driven primarily by tumor biology, and intracorporeal anastomosis does not increase recurrence risk.
-
Keywords: Robotic surgical procedures; Surgical anastomosis; Local neoplasm recurrence
INTRODUCTION
Minimally invasive surgery (MIS) has become the preferred approach for colorectal cancer due to its consistent perioperative benefits, including reduced blood loss and faster recovery compared to open techniques [1–4]. Among MIS techniques, laparoscopic colectomy has become particularly common and is consistently associated with reduced blood loss, less postoperative discomfort, and shorter hospitalization, while maintaining oncological outcomes comparable to those achieved with open resection [1–4]. Despite these benefits, the laparoscopic approach poses technical challenges. Intracorporeal anastomosis can be difficult to perform because straight laparoscopic instruments and a limited operative field constrain maneuverability [5]. As a result, extracorporeal anastomosis continues to be used in many cases, even though it generally requires a longer extraction incision and wider mobilization of the bowel, which has raised theoretical concerns regarding peritoneal dissemination [6].
Robotic-assisted surgery was developed to mitigate several of the intrinsic limitations of conventional laparoscopy. Robotic platforms provide enhanced instrument flexibility, tremor reduction, and immersive 3D visualization, enabling precise dissection in confined anatomical spaces. In rectal cancer surgery, robotic techniques have been reported to lower conversion rates, enhance visualization of pelvic autonomic nerves, and yield postoperative functional outcomes that are comparable—or, in some reports, superior—to those of laparoscopic surgery. Multiple randomized trials and large observational studies support these short-term advantages [7, 8]. However, long-term oncological benefit has not been consistently demonstrated, and most comparative analyses indicate similar disease-free and overall survival between robotic and laparoscopic rectal resections.
Use of robotic colectomy for colon cancer has also increased steadily. The robotic platform facilitates intracorporeal anastomosis, even in technically challenging situations. Intracorporeal anastomosis may offer several advantages, including a smaller extraction site, reduced traction on the bowel, and smoother postoperative recovery. Several studies have reported favorable perioperative outcomes with robotic colectomy compared with laparoscopy [9]. Nonetheless, robust evidence demonstrating oncological superiority remains limited. Only a few studies have examined recurrence patterns, and even fewer have evaluated the potential relationship between anastomotic technique and peritoneal dissemination [10, 11].
Some investigators have raised concerns that intracorporeal anastomosis, used more frequently in robotic surgery, may contribute to peritoneal recurrence through intraperitoneal contamination or tumor cell spillage [5, 12]. However, available evidence remains inconclusive. Furthermore, it remains unclear whether differences in recurrence patterns are attributable to surgical technique or underlying tumor biology. In Japan, large registry data based on the Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines indicate that peritoneal recurrence after curative colectomy for stage I–III colon cancer is relatively infrequent compared with distant metastases [13]. Despite its relatively low incidence, peritoneal recurrence represents a clinically important mode of failure due to its poor prognosis and limited treatment options. Importantly, few studies have evaluated recurrence patterns within a propensity score–matched framework that adequately controls for baseline differences between robotic and laparoscopic approaches.
To address this uncertainty, we performed a propensity score–matched comparison of robotic and laparoscopic colectomy for colon cancer. This study aimed to evaluate perioperative outcomes and oncological results, with particular attention to recurrence patterns, including peritoneal recurrence.
METHODS
Ethics statement
This study was approved by the Institutional Review Board of Nagasaki University Hospital (No. 23071002). The need for individual informed consent was waived because of the use of deidentified data and the retrospective nature of the study. All procedures were conducted in accordance with the principles of the Declaration of Helsinki.
Study design and patients
This was a retrospective cohort study conducted at Nagasaki University Hospital. Consecutive patients who underwent minimally invasive colectomy for primary colon adenocarcinoma between January 2016 and December 2024 were eligible. Patients with stage IV disease were included in the initial cohort; however, none were retained in the propensity score–matched cohort. Additional exclusion criteria were emergency surgery, synchronous malignancies, and insufficient clinical or follow-up data. Eligible patients were categorized according to surgical approach into laparoscopic colectomy (laparoscopic group) and robotic colectomy (robotic group).
Surgical procedures
All procedures were performed by board-certified colorectal surgeons experienced in minimally invasive techniques. The extent of resection and lymphadenectomy followed the JSCCR guidelines. Robotic colectomy was performed using the da Vinci Xi platform (Intuitive Surgical). Anastomosis was performed either intracorporeally or extracorporeally at the surgeon’s discretion. Intracorporeal anastomosis was constructed using a linear stapler with a delta-shaped configuration, whereas extracorporeal anastomosis was performed using a functional end-to-end anastomosis technique with stapling devices. Standard perioperative management protocols were applied across both groups.
Data collection and outcomes
Baseline demographic and clinical data included age, sex, body mass index (BMI), and American Society of Anesthesiologists (ASA) physical status. Tumor-related factors included clinical T and N categories, overall TNM stage, and tumor location. For pathological analysis, histologic type was categorized as well differentiated adenocarcinoma, moderately differentiated adenocarcinoma, poorly differentiated adenocarcinoma, mucinous adenocarcinoma, signet ring cell carcinoma, and others. For regression analyses, poorly differentiated adenocarcinoma, mucinous adenocarcinoma, and signet ring cell carcinoma were grouped as high-grade histology. These variables were also used to construct the propensity score for matching. Perioperative variables included operative time, estimated blood loss, conversion to open surgery, anastomotic method (intracorporeal vs. extracorporeal), and length of postoperative hospital stay.
The primary oncological outcomes were disease-free survival (DFS), locoregional/peritoneal recurrence-free survival (LRFS), and cancer-specific survival (CSS). DFS was defined as time from surgery to any recurrence or death from any cause. LRFS was defined as the time to locoregional or peritoneal recurrence within a competing risk framework in which death without prior locoregional/peritoneal recurrence was treated as a competing event; a sensitivity analysis treating death as censoring was also performed. CSS was defined as time to death due to colorectal cancer, with other-cause deaths censored. Recurrence patterns were categorized as locoregional, peritoneal, or distant metastases. In addition, outcomes were explored according to anastomotic technique (intracorporeal vs extracorporeal anastomosis). Recurrence and survival data were obtained from medical records, surveillance imaging, and follow-up visits. Follow-up was censored in June 2025.
Propensity score matching
To minimize selection bias between the robotic and laparoscopic groups, propensity score matching was performed. Propensity scores were estimated using a logistic regression model including age, sex, BMI, ASA physical status, clinical TNM stage, and surgical procedure. Patients were matched in a 1:1 ratio using nearest-neighbor matching without replacement with a caliper width of 0.2 of the standard deviation of the logit of the propensity score. Covariate balance was assessed using standardized mean differences (SMD). An SMD <0.1 was considered indicative of good balance, although values <0.2 were considered acceptable. After matching, 90 patients were included in each group for the comparative analyses.
Statistical analysis
Continuous variables were compared using the Student t-test or Mann-Whitney U-test, as appropriate. Categorical variables were analyzed using the chi-square test or Fisher exact test.
Survival outcomes, including DFS and CSS, were estimated using the Kaplan-Meier method and compared with the log-rank test. Survival curves were truncated at 36 months to ensure consistency between survival estimates and the number at risk, given the relatively shorter follow-up period in the robotic group. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using Cox proportional hazards models.
Median follow-up was estimated using the reverse Kaplan-Meier method. For recurrence pattern analyses, competing risk methods were applied. The cumulative incidence function of locoregional/peritoneal recurrence was estimated using the Fine-Gray subdistribution hazard model, with death without prior locoregional/peritoneal recurrence treated as a competing event. Group comparisons for cumulative incidence were performed using the Gray test, while subdistribution HRs were estimated using the Fine-Gray model. As a sensitivity analysis, LRFS was also evaluated using the Kaplan-Meier method with death treated as a censoring event.
To identify risk factors for peritoneal recurrence, univariable and multivariable analyses were performed using Firth’s penalized logistic regression because of the small number of recurrence events, thereby reducing small-sample bias and addressing sparse-data separation. Variables with a P-value of <0.10 in univariable analyses were included in the multivariable model. In addition, surgical approach was included as a clinically relevant variable regardless of its univariable significance. Histologic type was categorized as well differentiated adenocarcinoma, moderately differentiated adenocarcinoma, poorly differentiated adenocarcinoma, mucinous adenocarcinoma, signet ring cell carcinoma, and others. For regression analyses, poorly differentiated adenocarcinoma, mucinous adenocarcinoma, and signet ring cell carcinoma were grouped as high-grade histology.
All analyses were performed using R ver. 4.4.0 (R Foundation for Statistical Computing). A two-sided P-value of <0.05 was considered statistically significant.
RESULTS
Patient characteristics
A total of 591 patients underwent minimally invasive colectomy for colon cancer between January 2016 and December 2024, including 490 laparoscopic and 101 robotic procedures. After applying the exclusion criteria and performing propensity score matching, 180 patients were included in the matched cohort (robotic, n=90; laparoscopic, n=90) (Fig. 1). Baseline demographic and clinical characteristics were generally well balanced between the 2 groups after matching, with SMDs below the predefined threshold in most variables (Table 1).
Covariate balance before and after propensity score matching and the distribution of propensity scores after matching are shown in Supplementary Figs. 1 and 2, respectively.
Perioperative outcomes
Perioperative outcomes after propensity score matching are summarized in Table 2. Operative time was comparable between the robotic and laparoscopic groups (median, 199 minutes vs. 194 minutes; P=0.306). Estimated blood loss was significantly lower in the robotic group (median, 10 mL vs. 20 mL; P<0.001).
The rate of intracorporeal anastomosis was significantly higher in the robotic group compared with the laparoscopic group (92.2% vs. 24.4%, P<0.001). Conversion to open surgery, overall postoperative complications, and anastomotic leak rates did not differ significantly between groups. Postoperative hospital stay was significantly shorter in the robotic group (median, 9 days vs. 11.5 days; P<0.001).
Pathological outcomes
Pathological outcomes are summarized in Table 3. The number of harvested lymph nodes was significantly higher in the robotic group than in the laparoscopic group (median, 21.5 vs. 16.5; P<0.001). Histologic type differed between the groups (P=0.012). Other pathological parameters, including tumor size, pathological T and N categories, and resection margin status, were comparable between the 2 groups.
Oncological outcomes
The median follow-up time was 33 months, estimated using the reverse Kaplan-Meier method. DFS did not differ significantly between groups. At 24 months, DFS was 89.3% in the robotic group and 90.8% in the laparoscopic group (P=0.519) (Fig. 2A). In the present study, CSS was significantly higher in the robotic group (log-rank P=0.021); however, this finding should be interpreted cautiously because of the shorter follow-up period in the robotic cohort (Supplementary Fig. 3).
LRFS was higher in the robotic group (97.1% vs. 91.9% at 24 months, P=0.037) (Fig. 2B). However, competing risk analysis using the Fine-Gray model did not demonstrate a significant difference in the cumulative incidence of locoregional/peritoneal recurrence between groups (Fig. 3).
In multivariable analysis of risk factors for peritoneal recurrence, tumor-related pathological factors, particularly high-grade histology was significantly associated with recurrence risk, whereas surgical approach was not independently associated with peritoneal recurrence (Table 4). Because the robotic group had a relatively shorter follow‑up period and the number of patients at risk markedly decreased beyond 36 months, all Kaplan-Meier curves were truncated at 36 months to avoid overinterpretation of unstable estimates.
Intracorporeal vs. extracorporeal anastomosis
To further explore the potential relationship between anastomotic technique and recurrence patterns, an additional analysis comparing intracorporeal and extracorporeal anastomosis was performed. Kaplan-Meier analysis demonstrated no significant difference in LRFS between the intracorporeal and extracorporeal anastomosis groups (Fig. 4). These findings suggest that the higher use of intracorporeal anastomosis in robotic surgery did not contribute to an increased risk of peritoneal recurrence.
DISCUSSION
In this propensity score–matched analysis, we compared robotic and laparoscopic colectomy for colon cancer with particular attention to perioperative outcomes and recurrence patterns, including peritoneal involvement. Robotic surgery was associated with reduced blood loss, shorter postoperative hospitalization, and markedly higher use of intracorporeal anastomosis, without prolonging operative time. Kaplan-Meier analysis suggested a lower rate of locoregional/peritoneal recurrence in the robotic group. However, competing risk analysis did not demonstrate a significant difference in cumulative incidence between groups. Furthermore, multivariable analysis indicated that tumor-related factors, rather than surgical approach, were independently associated with peritoneal recurrence.
The perioperative advantages observed in this study are consistent with previous reports describing reduced intraoperative blood loss and faster early recovery after robotic colectomy compared with laparoscopy [9, 11, 14, 15]. Several meta-analyses have suggested that robotic procedures are generally associated with longer operative times [4, 5, 16]. In contrast, operative time was not prolonged in the robotic group in our study. A plausible explanation is the high level of operator experience at our center; all robotic operations were carried out by surgeons who had previously completed more than 50 robotic colectomies. Such accumulated expertise may mitigate the commonly reported disadvantage of prolonged operative duration in robotic colectomy, a trend echoed in reports from other high-volume institutions with structured training programs [1, 14].
Another notable finding was the greater number of lymph nodes retrieved during robotic colectomy. Adequate lymphadenectomy is an established indicator of oncological quality in colon cancer surgery [6]. Previous comparative studies have also reported higher nodal yields with robotic techniques compared with laparoscopy [17, 18]. The improved instrument articulation and enhanced 3D visualization provided by robotic systems may facilitate more precise mesocolic dissection and lymphadenectomy. In addition, the frequent use of intracorporeal anastomosis in robotic colectomy may contribute indirectly, as this technique often requires more complete mobilization of the colon and mesentery. Taken together, these factors suggest that robotic colectomy can achieve oncological quality comparable to that of laparoscopic surgery with respect to lymph node retrieval.
An important aspect of the present study was the detailed assessment of recurrence patterns, particularly peritoneal dissemination. Intracorporeal anastomosis has occasionally been questioned as a potential risk factor for intraperitoneal tumor cell spread, although the available evidence remains inconclusive [5, 12]. In our cohort, the use of intracorporeal anastomosis was substantially higher in the robotic group; however, no increase in peritoneal or locoregional recurrence was observed. Additional exploratory analysis comparing intracorporeal and extracorporeal anastomosis also demonstrated no significant difference in recurrence patterns. These findings are consistent with several recent systematic reviews and meta-analyses indicating that intracorporeal anastomosis does not compromise oncological safety and may offer perioperative advantages, including smaller extraction sites and faster postoperative recovery [5, 10, 12, 19].
The mechanisms underlying peritoneal recurrence are likely multifactorial. Although technical factors such as tumor manipulation or intraperitoneal contamination have been proposed, our multivariable analysis suggested that tumor-related characteristics, particularly high-grade histology, were more strongly associated with peritoneal recurrence than the surgical approach itself. These findings support the validity of grouping high-grade histology in the regression analysis. Taken together, these results suggest that intracorporeal anastomosis does not increase the risk of peritoneal dissemination, and that tumor biology plays a dominant role in determining recurrence patterns.
Consistent with most prior comparisons, DFS did not differ substantially between robotic and laparoscopic colectomy [10, 11]. Large database studies and meta-analyses also suggest equivalent DFS and overall survival between the 2 modalities [20]. In the present study, CSS was significantly higher in the robotic group (log-rank P=0.021); however, this finding should be interpreted cautiously because of the shorter follow-up period in the robotic cohort. Although some reports have suggested potential survival advantages in selected patient populations, such as older adults [21], the overall evidence remains largely equivalent. This discrepancy may reflect differences in the handling of competing events and censoring, suggesting that the apparent advantage observed in Kaplan-Meier analysis may reflect statistical bias rather than a true difference in recurrence risk. Competing risk models are particularly useful in colorectal cancer research because non–cancer-related deaths may preclude the observation of recurrence events and thereby bias conventional survival estimates [22–24]. Although the median follow-up period was shorter in the robotic cohort, this analytical framework allows more appropriate estimation of recurrence risk by accounting for competing mortality.
Taken together, the present findings suggest that robotic colectomy offers perioperative advantages while maintaining oncological outcomes comparable to those of laparoscopic surgery. In particular, the robotic approach facilitated the frequent use of intracorporeal anastomosis without increasing the risk of peritoneal dissemination. Given that peritoneal recurrence remains a clinically relevant pattern of failure after curative colectomy, especially among patients with adverse tumor characteristics [25, 26], reassurance regarding the oncological safety of intracorporeal anastomosis is important. These results support the view that robotic colectomy represents a safe and reasonable minimally invasive option for colon cancer surgery when performed in experienced centers with established techniques for intracorporeal anastomosis and appropriate oncological resection.
Limitations
This study has several limitations. First, its retrospective design and single-institution setting introduce the possibility of residual confounding, even after propensity score matching. Second, the robotic approach was implemented later during the study period, resulting in a shorter median follow-up in the robotic cohort, which may limit the assessment of long-term oncological outcomes such as CSS. Third, although matching produced well-balanced cohorts, the overall sample size remains relatively modest for detecting small differences in oncological outcomes, particularly for uncommon events such as peritoneal recurrence. Fourth, recurrence patterns were determined based on clinical records and imaging findings rather than standardized prospective surveillance protocols, which may introduce some degree of misclassification. Finally, the subgroup analysis comparing intracorporeal and extracorporeal anastomosis was exploratory in nature and should therefore be interpreted with caution.
Conclusions
In this propensity score–matched analysis, robotic colectomy for colon cancer demonstrated favorable perioperative outcomes, including reduced blood loss and shorter postoperative hospital stay, while maintaining oncological outcomes comparable to those of laparoscopic colectomy. Although intracorporeal anastomosis was performed far more frequently in the robotic group, no increase in locoregional or peritoneal recurrence was observed. These findings suggest that intracorporeal anastomosis is oncologically safe and that peritoneal recurrence is primarily driven by tumor biology rather than surgical approach. Further multicenter studies with longer follow-up are warranted to confirm these observations.
ARTICLE INFORMATION
-
Conflict of interest
No potential conflict of interest relevant to this article was reported..
-
Funding
None.
-
Acknowledgments
The authors thank Mariko Yamashita and Yuma Takamura (Division of Surgical Oncology, Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences) for their assistance in data preparation; and Fumitake Uchida (Department of Surgery, Ureshino Medical Center) and Kaido Oishi (Department of Surgery, National Hospital Organization Nagasaki Medical Center) for their contributions to the verification of surgical quality.
-
Author contributions
Conceptualization: TN; Data curation: KN, TT, HK, SH, MH, HT, KT, HF; Formal analysis: TN, KN; Investigation: TT, HK, SH, MH, HT, KT, HF; Methodology: all authors; Project administration: TN; Supervision: TN, KM; Writing–original draft: TN; Writing–review & editing: all authors. All authors read and approved the final manuscript.
Supplementary materials
Supplementary materials are available from https://doi.org/10.3393/ac.2026.00213.0030.
Fig. 1.Flow diagram of patient selection and propensity score matching. BMI, body mass index; ASA, American Society of Anesthesiologists.
Fig. 2.Kaplan-Meier analysis of (A) disease-free survival (DFS) and (B) locoregional/peritoneal recurrence-free survival (LRFS) after laparoscopic versus robotic colectomy.
Fig. 3.Competing risk analysis of (A) locoregional/peritoneal recurrence and (B) death without recurrence.
Fig. 4.Locoregional/peritoneal recurrence-free survival (LRFS) according to anastomotic technique. ECA, extracorporeal anastomosis; ICA, intracorporeal anastomosis.
Table 1.Baseline characteristics before and after propensity score matching
|
Characteristic |
Before matching |
After matching |
|
Laparoscopic (n=490) |
Robotic (n=101) |
P-value |
Laparoscopic (n=90) |
Robotic (n=90) |
P-value |
|
Age (yr) |
71 (25–94) |
70 (33–86) |
0.282 |
71.5 (37–91) |
70.0 (33–86) |
0.745 |
|
Sex |
|
|
0.662 |
|
|
>0.999 |
|
Male |
233 (47.6) |
51 (50.5) |
|
47 (52.2) |
47 (52.2) |
|
|
Female |
257 (52.4) |
50 (49.5) |
|
43 (47.8) |
43 (47.8) |
|
|
BMI (kg/m2) |
22.0 (13.4–36.0) |
22.4 (16.4–30.8) |
0.573 |
21.7 (15.1–34.0) |
22.4 (16.4–30.8) |
0.125 |
|
ASA physical status |
|
|
0.858 |
|
|
0.651 |
|
I |
143 (29.2) |
27 (26.7) |
|
29 (32.2) |
24 (26.7) |
|
|
II |
306 (62.4) |
66 (65.3) |
|
53 (58.9) |
59 (65.6) |
|
|
III |
41 (8.4) |
8 (7.9) |
|
8 (8.9) |
7 (7.8) |
|
|
IV |
0 (0) |
0 (0) |
|
0 (0) |
0 (0) |
|
|
Clinical T category |
|
|
0.390 |
|
|
0.677 |
|
cT1 |
162 (33.1) |
39 (38.6) |
|
33 (36.7) |
36 (40) |
|
|
cT2 |
77 (15.7) |
11 (10.9) |
|
8 (8.9) |
9 (10.0) |
|
|
cT3 |
191 (39.0) |
42 (41.6) |
|
36 (40.0) |
37 (41.1) |
|
|
cT4 |
60 (12.2) |
9 (8.9) |
|
13 (14.4) |
8 (8.9) |
|
|
Clinical N category |
|
|
0.071 |
|
|
0.280 |
|
cN0 |
325 (66.3) |
78 (77.2) |
|
64 (71.1) |
68 (75.6) |
|
|
cN1 |
115 (23.5) |
20 (19.8) |
|
17 (18.9) |
19 (21.1) |
|
|
cN2 |
43 (8.8) |
3 (3.0) |
|
7 (7.8) |
3 (3.3) |
|
|
cN3 |
7 (1.4) |
0 (0) |
|
2 (2.2) |
0 (0) |
|
|
Clinical stage |
|
|
0.009 |
|
|
0.616 |
|
I |
224 (45.7) |
50 (49.5) |
|
38 (42.2) |
44 (48.9) |
|
|
II |
90 (18.4) |
28 (27.7) |
|
25 (27.8) |
24 (26.7) |
|
|
III |
134 (27.3) |
22 (21.8) |
|
27 (30.0) |
22 (24.4) |
|
|
IV |
42 (8.6) |
1 (1.0) |
|
0 (0) |
0 (0) |
|
|
Procedure |
|
|
0.001 |
|
|
0.934 |
|
Ileocecal resection |
88 (18.0) |
10 (9.9) |
|
10 (11.1) |
10 (11.1) |
|
|
Right hemicolectomy |
144 (29.4) |
53 (52.5) |
|
47 (52.2) |
48 (53.3) |
|
|
Transverse colectomy |
12 (2.4) |
3 (3.0) |
|
2 (2.2) |
2 (2.2) |
|
|
Left hemicolectomy |
52 (10.6) |
15 (14.9) |
|
17 (18.9) |
13 (14.4) |
|
|
Sigmoidectomy |
194 (39.6) |
20 (19.8) |
|
14 (15.6) |
17 (18.9) |
|
|
Preoperative treatment |
12 (2.4) |
1 (1.0) |
0.707 |
0 (0) |
1 (1.1) |
>0.999 |
Table 2.Perioperative outcomes after propensity score matching (n=180)
|
Outcome |
Laparoscopic (n=90) |
Robotic (n=90) |
P-value |
|
With adjacent organ resection |
1 (1.1) |
0 (0) |
>0.999 |
|
Intracorporeal anastomosis |
22 (24.4) |
83 (92.2) |
<0.001 |
|
Operative time (min) |
194 (102–351) |
199 (140–328) |
0.306 |
|
Blood loss (mL) |
20 (0–516) |
10 (0–315) |
<0.001 |
|
Conversion |
0 (0) |
0 (0) |
- |
|
Postoperative complication |
27 (30.0) |
20 (22.2) |
0.308 |
|
Clavien-Dindo grade ≥III |
6 (6.7) |
4 (4.4) |
0.746 |
|
Anastomotic leakage |
4 (4.4) |
2 (2.2) |
0.682 |
|
Postoperative hospital stay (day) |
11.5 (7–38) |
9 (7–31) |
<0.001 |
Table 3.Pathological outcomes after propensity score matching
|
Outcome |
Laparoscopic (n=90) |
Robotic (n=90) |
P-value |
|
No. of harvested lymph nodes |
16.5 (5–53) |
21.5 (3–70) |
<0.001*
|
|
Tumor diameter (mm) |
30 (0–100) |
32 (9–111) |
0.379 |
|
Histology |
|
|
0.012*
|
|
Well differentiated |
50 (55.6) |
30 (33.3) |
|
|
Moderately differentiated |
32 (35.6) |
52 (57.8) |
|
|
Poorly differentiated |
4 (4.4) |
1 (1.1) |
|
|
Mucinous adenocarcinoma |
4 (4.4) |
4 (4.4) |
|
|
Signet ring cell carcinoma |
0 (0) |
1 (1.1) |
|
|
Other |
0 (0) |
2 (2.2) |
|
|
Pathologic T category |
|
|
0.793 |
|
pT1 |
30 (33.3) |
35 (38.9) |
|
|
pT2 |
8 (8.9) |
6 (6.7) |
|
|
pT3 |
47 (52.2) |
45 (50.0) |
|
|
pT4 |
5 (5.6) |
4 (4.4) |
|
|
Pathologic N category |
|
|
0.514 |
|
pN0 |
64 (71.1) |
65 (72.2) |
|
|
pN1 |
20 (22.2) |
20 (22.2) |
|
|
pN2 |
5 (5.6) |
2 (2.2) |
|
|
pN3 |
1 (1.1) |
3 (3.3) |
|
|
Lymphovascular invasion |
52 (57.8) |
48 (53.3) |
0.653 |
|
Pathologic stage |
|
|
0.880 |
|
I |
36 (40.0) |
37 (41.1) |
|
|
II |
29 (32.2) |
26 (28.9) |
|
|
III |
25 (27.8) |
27 (30.0) |
|
|
IV |
0 (0) |
0 (0) |
|
|
Proximal margin status |
|
|
- |
|
PM0 |
90 (100) |
90 (100) |
|
|
PM1 |
0 (0) |
0 (0) |
|
|
PM2 |
0 (0) |
0 (0) |
|
|
Distal margin status |
|
|
- |
|
DM0 |
90 (100) |
90 (100) |
|
|
DM1 |
0 (0) |
0 (0) |
|
|
DM2 |
0 (0) |
0 (0) |
|
|
Radial margin status |
|
|
>0.999 |
|
RM0 |
89 (98.9) |
90 (100) |
|
|
RM1 |
1 (1.1) |
0 (0) |
|
|
RM2 |
0 (0) |
0 (0) |
|
|
Residual tumor statusa
|
|
|
>0.999 |
|
R0 |
89 (98.9) |
90 (100) |
|
|
R1 |
1 (1.1) |
0 (0) |
|
|
R2 |
0 (0) |
0 (0) |
|
Table 4.Risk factors for peritoneal recurrence
|
Factor |
Univariable analysis |
Multivariable analysis |
|
OR (95% CI) |
P-value |
OR (95% CI) |
P-value |
|
Surgical approach |
|
|
|
|
|
Laparoscopic |
1 (Reference) |
|
1 (Reference) |
|
|
Robotic |
0.44 (0.08–1.88) |
0.272 |
0.49 (0.08–2.25) |
0.361 |
|
Intracorporeal anastomosis |
|
|
|
|
|
No |
1 (Reference) |
|
|
|
|
Yes |
0.92 (0.22–4.22) |
0.907 |
|
|
|
High-grade histologya
|
|
|
|
|
|
No |
1 (Reference) |
|
1 (Reference) |
|
|
Yes |
10.99 (2.23–51.11) |
0.005 |
7.56 (1.46–37.91) |
0.018 |
|
Pathologic T category |
|
|
|
|
|
pT1–pT3 |
1 (Reference) |
|
|
|
|
pT4 |
4.00 (0.39–22.13) |
0.204 |
|
|
|
Pathologic N category |
|
|
|
|
|
pN– |
1 (Reference) |
|
1 (Reference) |
|
|
pN+ |
6.60 (1.53–37.80) |
0.011 |
2.98 (0.65–17.51) |
0.161 |
|
Lymphovascular invasion |
|
|
|
|
|
No |
1 (Reference) |
|
1 (Reference) |
|
|
Yes |
13.22 (1.57–1,725.07) |
0.012 |
7.33 (0.77–971.01) |
0.090 |
REFERENCES
- 1. Fujii S, Akagi T, Inomata M, Katayama H, Mizusawa J, Ota M, et al. Transitional impact of short- and long-term outcomes of a randomized controlled trial to evaluate laparoscopic versus open surgery for colorectal cancer from Japan Clinical Oncology Group Study JCOG0404. Ann Gastroenterol Surg 2019;3:301–9. ArticlePubMedPMC
- 2. COLOR Study Group. COLOR: a randomized clinical trial comparing laparoscopic and open resection for colon cancer. Dig Surg 2000;17:617–22. ArticlePubMedPDF
- 3. Jayne DG, Thorpe HC, Copeland J, Quirke P, Brown JM, Guillou PJ. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg 2010;97:1638–45. ArticlePubMedPDF
- 4. Fleshman J, Sargent DJ, Green E, Anvari M, Stryker SJ, Beart RW, et al. Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial. Ann Surg 2007;246:655–62. ArticlePubMed
- 5. Zhang H, Sun N, Fu Y, Zhao C. Intracorporeal versus extracorporeal anastomosis in laparoscopic right colectomy: updated meta-analysis of randomized controlled trials. BJS Open 2021;5:zrab133.ArticlePubMedPMCPDF
- 6. Vaghiri S, Prassas D, Krieg S, Knoefel WT, Krieg A. Intracorporeal versus extracorporeal colo-colic anastomosis in minimally-invasive left colectomy: a systematic review and meta-analysis. J Gastrointest Surg 2023;27:3024–37. ArticlePubMedPMCPDF
- 7. Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, et al. Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial. JAMA 2017;318:1569–80. ArticlePubMedPMC
- 8. Mirza W, Dadan S, Khan HM, Yasmin S. Robotic versus laparoscopic surgery for rectal cancer: a systematic review and meta-analysis of randomized trials evaluating functional recovery, complication risk, and oncologic quality. J Robot Surg 2025;19:457.ArticlePubMedPDF
- 9. Ueda K, Iwamoto M, Yane Y, Makutani Y, Yoshioka Y, Daito K, et al. Robot-assisted vs. laparoscopic rectal cancer resection: a narrative review of oncological outcomes, functional results, and future perspectives. Mini-invasive Surg 2025;9:21.Article
- 10. Wei P, Li Y, Gao J, Wu S, Shu W, Yao H, et al. Intracorporeal versus extracorporeal anastomosis in laparoscopic right hemicolectomy: an updated systematic review and meta-analysis of randomized control trials. Dig Surg 2024;41:224–44. ArticlePubMedPDF
- 11. Gahunia S, Wyatt J, Powell SG, Mahdi S, Ahmed S, Altaf K. Robotic-assisted versus laparoscopic surgery for colorectal cancer in high-risk patients: a systematic review and meta-analysis. Tech Coloproctol 2025;29:98.ArticlePubMedPMCPDF
- 12. Kim A, Nyandoro MG, Vu L, Rajan R, Jacob A. Single-center experiences: a comparison of intracorporeal and extracorporeal anastomosis outcomes in right hemicolectomy. Cureus 2024;16:e59339. ArticlePubMedPMC
- 13. Kinugasa Y, Uehara K, Yamaguchi K, Saito Y, Murofushi K, Sugai T, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer. Int J Clin Oncol 2025;30:2410–63. ArticlePubMedPMCPDF
- 14. Negrut RL, Cote A, Caus VA, Maghiar AM. Systematic review and meta-analysis of laparoscopic versus robotic-assisted surgery for colon cancer: efficacy, safety, and outcomes-a focus on studies from 2020-2024. Cancers (Basel) 2024;16:1552.ArticlePubMedPMC
- 15. Farah E, Abreu AA, Rail B, Salgado J, Karagkounis G, Zeh HJ, et al. Perioperative outcomes of robotic and laparoscopic surgery for colorectal cancer: a propensity score-matched analysis. World J Surg Oncol 2023;21:272.ArticlePDF
- 16. Tschann P, Szeverinski P, Weigl MP, Rauch S, Lechner D, Adler S, et al. Short- and long-term outcome of laparoscopic- versus robotic-assisted right colectomy: a systematic review and meta-analysis. J Clin Med 2022;11:2387.ArticlePubMedPMC
- 17. Chen E, Zhang W, Chen L. Robotic right colectomy versus laparoscopic right colectomy in patients with right colon cancer: a comparative study. BMC Surg 2024;24:332.ArticlePubMedPMCPDF
- 18. Butnari V, Sultana M, Mansuri A, Rao C, Kaul S, Boulton R, et al. Comparison of early surgical outcomes of robotic and laparoscopic colorectal cancer resection reported by a busy district general hospital in England. Sci Rep 2024;14:9227.ArticlePubMedPMCPDF
- 19. Brown RF, Cleary RK. Intracorporeal anastomosis versus extracorporeal anastomosis for minimally invasive colectomy. J Gastrointest Oncol 2020;11:500–7. ArticlePubMedPMC
- 20. Willis F, Amati AL, Reichert M, Hecker A, Vilz TO, Kalff JC, et al. Current evidence in robotic colorectal surgery. Cancers (Basel) 2025;17:2503.ArticlePubMedPMC
- 21. Pacheco F, Harris-Gendron S, Luciano E, Zreik J, Kamel MK, Solh WA. Robotic versus laparoscopic colectomy outcomes in colon adenocarcinoma in the elderly population: a propensity-score matched analysis of the National Cancer Database. Int J Colorectal Dis 2023;38:183.ArticlePubMedPDF
- 22. Schellenberg AE, Moravan V, Christian F. A competing risk analysis of colorectal cancer recurrence after curative surgery. BMC Gastroenterol 2022;22:95.ArticlePubMedPMCPDF
- 23. Wang Z, Wang Y, Yang Y, Luo Y, Liu J, Xu Y, et al. A competing-risk nomogram to predict cause-specific death in elderly patients with colorectal cancer after surgery (especially for colon cancer). World J Surg Oncol 2020;18:30.ArticlePubMedPMCPDF
- 24. Caspers IA, Sikorska K, Slagter AE, van Amelsfoort RM, Meershoek-Klein Kranenbarg E, van de Velde CJ, et al. Risk factors for metachronous isolated peritoneal metastasis after preoperative chemotherapy and potentially curative gastric cancer resection: results from the CRITICS trial. Cancers (Basel) 2021;13:4626.ArticlePubMedPMC
- 25. Mayanagi S, Kashiwabara K, Honda M, Oba K, Aoyama T, Kanda M, et al. Risk factors for peritoneal recurrence in stage II to III colon cancer. Dis Colon Rectum 2018;61:803–8. ArticlePubMedPMC
- 26. Aiken T, Hu CY, Uppal A, Francescatti AB, Fournier KF, Chang GJ, et al. Peritoneal recurrence after resection for stage I-III colorectal cancer: a population analysis. J Surg Oncol 2023;127:678–87. ArticlePubMedPDF
Citations
Citations to this article as recorded by
